Two New AI Co-Pilots for Staff and Insights Offered Alongside
Multiple Artera Harmony Platform Updates
SANTA BARBARA, Calif., Oct. 18, 2024 /PRNewswire/ — Artera, the leader in patient communications and trusted partner to more than 800 healthcare organizations, unveiled its latest AI products at the Artera Heartbeat Annual Customer Conference. With a mission to make healthcare number one in customer service, Artera announced two new AI-powered products — Artera Staff AI Co-Pilot and Artera Insights AI Co-Pilots — and significant updates to its award-winning patient communications platform, Artera Harmony.
These advancements aim to enhance patient experience, streamline healthcare operations and reduce administrative burden.
Artera Staff AI Co-Pilot:
The Artera Staff AI Co-Pilot is designed using healthcare conversational data to assist administrative staff in managing patient communications faster and more accurately. The Staff AI Co-Pilot includes four skills to improve patient communications, increase response time and reduce administrative staff burden:
Artera Insights AI Co-Pilot:
Designed to help healthcare organizations make data-driven decisions, the Artera Insights AI Co-Pilot analyzes patient engagement data to provide actionable insights and timely recommendations. Currently available are:
Coming in Q1 2025:
Artera Harmony Enhancements
Artera continues to enhance Artera Harmony, the award-winning patient communications SaaS platform, leveraged by today’s leading healthcare organizations. At Artera Heartbeat’24, several new Harmony features were unveiled:
Coming in Q1 2025:
About Artera Heartbeat
Artera Heartbeat is Artera’s premier customer conference for healthcare leaders seeking to transform patient communication. The event brings together industry experts, thought leaders and Artera customers to discuss the future of healthcare communication and showcase the latest innovations from Artera, Artera customers and Artera Marketplace Partners. Attendees benefit from hands-on workshops, visionary keynote sessions, affinity sessions with like-minded leaders and exclusive access to the latest product updates from Artera.
About Artera
Artera is a SaaS digital health leader redefining patient communications. Artera is trusted by 800+ healthcare systems and federal agencies to facilitate approximately 2 billion communications annually, reaching 100+ million patients. The Artera platform integrates across a healthcare organization’s tech stack, EHRs and third-party vendors to unify, simplify and orchestrate digital communications into the patient’s preferred channel (texting, email, IVR, and webchat), in 109+ languages. The Artera impact: more efficient staff, more profitable organizations and a more harmonious patient experience.
Founded in 2015, Artera is based in Santa Barbara, California and has been named a Deloitte Technology Fast 500 company (2021, 2022, 2023), and ranked on the Inc. 5000 list of fastest-growing private companies for five consecutive years. Artera is a two-time Best in KLAS winner in Patient Outreach.
For more information, visit www.artera.io.
Forward-looking statements: These statements are based on current information and are subject to change without notice. They may not be accurate or reliable, and actual events may differ from those projected.
Disclaimer of responsibility: The company is not responsible for the correctness, completeness, or accuracy of the statements. The company also excludes claims for damages based on the press release.
Right to make changes: Artera reserves the right to make changes without notice in design, specifications, and models. The only warranty Artera makes is the express written warranty extended on the sale of its service(s) and/or product(s).
SOURCE Artera
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…